Is this the main reason why Guardion Health Sciences (GHSI) shares surged in the after-hours?
Guardion Health Sciences, (GHSI) serves as a specialist health sciences corporation in the United States and its subsidiaries. The organization works in two divisions, medical food, and medical devices. Medical Foods provides Lumega-Z, balanced nutrition that refills and replaces the macular antioxidant pigment, and GlaucoCetin. This vision-specific medical food promotes and preserves the optic nerve […]
Let’s take a look at how Venus Concept Inc. (VERO) plunged in the Pre-market
NASDAQ-listed Venus Concept Inc. (VERO), shares plunged 18.5% to $2.07 in the early hours today after a global medical aesthetic technology leader announced that it aims to make an underwritten public offering of Venus common stock under its existing shelf registration statement, subject to pertinent market and other conditions. Venus Concept will be selling all […]
TOP Losers Today in Pre Market
Pre-market data show Naked Brand Group Limited (NASDAQ:NAKD) is -2.44% lower at $0.1561. It recently closed at $0.16, fluctuating in a day’s range from $0.1426 to $0.169 and a 52-week trading range of $0.07 to $3.70. Zomedica Corp. (AMEX:ZOM) is trading at $0.1591 down with -2.15 percent or -0.0 point in pre-market trading today. It […]
Is that why TCR2 Therapeutics Inc. (Nasdaq: TCRR) shares soared in the late hours on Friday?
TCR2 Therapeutics Inc. (Nasdaq: TCRR), the stock surged higher in the after-market session as it was up 33.36% to $43.6. As a clinical-stage immunotherapy company with a pipeline of novel T cell-based therapies for cancer patients, we revealed today positive interim results from the Phase 1 portion of the TC-210 Phase 1/2 clinical trial. In […]
There You Go: This update made Medley Capital Corporation (NYSE: MCC) stock fall in the after-hours session
Medley Capital Corporation (NYSE: MCC) dipped in the after-hours period as the financial reports for the quarter ended September 30, 2020, were released today by the Company. During the quarter, ended September 30, 2020, the Company had a net investment loss of $0.32 per share and a net income of $0.47 per share, calculated based […]
Is this a coincidence, or this news made Destination XL Group (DXLG) nosedived in the After-market session?
Destination XL Group (DXLG) stock plummeted -30.84% to $0.21 in the AH sessions as the biggest omnichannel specialty retailer of big and tall men’s clothing continues to confidently anticipate a path to recovery from the COVID-19 pandemic in the fiscal year 2021. For the 9-week holiday period ending January 2, 2021, the company expects to […]
No matter how Codexis (Nasdaq: CDXS) shares jumped in the late session on Friday
A leading protein engineering firm, Codexis (Nasdaq: CDXS), stock in postmarket trade has grown 14.17% to $7.001. There does not seem to be any business news that today prompted the price of Codexis share to surge, and investors would want to take this as a signal for warning. However, on December 02, 2020, the pricing […]
Why did Century Aluminum of South Carolina (CASC) stock slide in the After-hours session?
Century Aluminum of South Carolina (CASC) shares value dropped in the after-market session on Friday night as, a fully owned subsidiary of Century Aluminum Company, revealed today that it had reached an agreement on the principal terms of a new, three-year power contract with the South Carolina Public Service Authority for its Mt. Holly aluminum […]
Is that why Aerpio Pharmaceuticals (Nasdaq: ARPO) stock plunged in the AH session?
Aerpio Pharmaceuticals, (Nasdaq: ARPO), the stock dipped -40.89% to $1.33 in the After-market session, as Razuprotafib met its primary efficacy endpoint at 28 days in Aerpio’s double-blind Phase 2 trial in patients with elevated intraocular pressure associated with open-angle glaucoma and ocular hypertension. Compared to the monotherapy group, razuprotafib did not show any statistically significant […]
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) shares up in the sky after this update
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) stock soared 17.36% to $1.42 in the pre-market trading session following an announcement by a biopharmaceutical corporation focusing on advancing immunology-based treatments for common inflammatory disorders that two collaboration have been reached to explore potential therapeutic applications for its immunomodulatory drug, Ampion. The Organization has entered into a cooperative […]
